Invitation to Roche’s Pharma Day 2023 Freitag, 21. Juli 2023 - 10:26

Investor Update

Invitation to Roche's Pharma Day 2023

The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 11 September 2023, starting at 10:00 BST and will finish at 14:30 BST with a reception. The Roche Pharma Day will address the following topics: Group / Pharma strategy Commercial growth drivers Pipeline updates Oncology, Hematology, Neuroscience, Ophthalmology, Immunology Presenters include: Thomas Schinecker, CEO Roche Group Teresa Graham, CEO Roche Pharmaceuticals Levi Garraway, Chief Medical Officer and Head of Global Product Development Charlie Fuchs, Senior Vice President and Global Head of Oncology and Hematology Paulo Fontoura, Senior Vice President and Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases Clinical Development Christopher Brittain, Vice President and Global Head Product Development Ophthalmology You will have the opportunity to meet senior management during the event. Meeting information: Date/Time (BST): Monday, 11 September 2023 10:00 Registration 10:30 Event starts 14:30 Event ends, followed by refreshments with Roche Management Team Venue etc.venues St Paul's 200 Aldersgate London EC1A 4HD map To register for the event, please follow this > li n k (passcode: Pharma2023) The slides will be available for download at 9:30 BST on the day of the event. > click here Alternatively you may participate virtually in the webinar. (no access to speakers, pre-registration required) Please pre-register for the webinar here. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com . A replay of the event will be available via > ir.roche.com privacy notice Best regards,
Bruno Eschli Head of Investor Relations	Loren Kalm Head of Investor Relations North America


Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com